Business Context and Reporting Period
This Form 8-K is filed by TRxADE HEALTH, INC. (noting a discrepancy with the metadata company name "Scienture Holdings, Inc.") on November 21, 2023. The report addresses a regulatory compliance issue regarding the timely filing of periodic reports with the SEC.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on listing compliance status.
Material Changes
- Delisting Notice: On November 21, 2023, the Company received a notice from Nasdaq indicating non-compliance with Listing Rule 5250(c)(1) due to the failure to timely file its Form 10-Q for the period ended September 30, 2023.
- Previous Action: The Company had previously filed a Form 12b-25 on November 15, 2023, requesting additional time to complete the Form 10-Q.
Outlook, Risks, and Management Commentary
- Immediate Impact: The notice has no immediate effect on the listing or trading of the Company's common stock.
- Compliance Plan Deadline: The Company must submit a plan to regain compliance to Nasdaq no later than January 22, 2024 (noting the source text erroneously states "January 22, 2023," which is logically inconsistent with the filing date).
- Extension Possibility: Upon receipt of the plan, Nasdaq may grant an extension of up to 180 calendar days from the Form 10-Q due date, potentially until May 20, 2024.
- Management Stance: Management states it is working diligently to file the Form 10-Q as soon as practicable but provides no assurances regarding the specific timing.
- Risk: Further delays in filing the Form 10-Q could impact the listing or trading of the Company's common stock.
Investor Verification Checklist
- Verify the correct registrant name (TRxADE HEALTH, INC. vs. metadata reference to Scienture Holdings, Inc.).
- Monitor the submission of the compliance plan to Nasdaq by the January 22, 2024 deadline.
- Track the actual filing date of the Form 10-Q for the period ended September 30, 2023.
- Watch for any subsequent Nasdaq communications regarding the approval of the compliance plan or potential delisting.